Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
Diabetes Metabolic Syndrome and Obesity2014Vol. 7, pp. 229–229
Citations Over TimeTop 17% of 2014 papers
Abstract
Once weekly treatment options for diabetes such as exenatide ER have the potential to offer substantial convenience for patients who have high medication burden and poor medication adherence.
Related Papers
- → Liraglutide vs Exenatide: Patient Adherence, Medication Persistence and Economic Evaluation in the Treatment of Type 2 Diabetes Mellitus(2014)3 cited
- → Use of exenatide and liraglutide in Denmark: a drug utilization study(2013)12 cited
- → Is liraglutide or exenatide better in type 2 diabetes?(2009)2 cited
- → P-1405 Glycaemic control improves in type 2 diabetes patients when switching from twice-daily exenatide to once-daily liraglutide(2009)
- Liraglutide. Type 2 diabetes: more prudent to continue using exenatide.(2010)